Quinidine
is a
pharmaceutical
agent that acts as a
class I antiarrhythmic agent in the
heart. It is a
stereoisomer of
quinine, originally derived from the bark of the
cinchona tree.Like all other class I
antiarrhythmic agents,
quinidine primarily works by blocking
the fast inward
sodium current (INa).
Quinidine's effect on
INa is known as a use
dependent block. This means that at higher heart rates, the block
increases, while at lower heart rates the block decreases. The
effect of blocking the fast inward sodium current causes the phase 0
depolarization of the
cardiac action potential to decrease (decreased
Vmax).Quinidine
also blocks the slowly inactivating
tetrodotoxin-sensitive
Na current, the slow inward
calcium current (ICa),
the rapid (IKr) and slow (IKs)
components of the delayed potassium rectifier current, the inward
potassium rectifier current (IKI),
the ATP-sensitive potassium channel (IKATP)
and Ito.The effect of
quinidine on the ion channels is to
prolong the cardiac action potential, thereby prolonging the QT
interval on the surface
EKG.The half life of oral
quinidine is 6 to 8 hours, and it is
eliminated by the
cytochrome P450 system in the liver.
About 20 percent is excreted unchanged via the kidneys.Qunidine-induced
thrombocytopenia (low platelet count) is mediated by the
immune system, and may lead to thrombocytic
purpura.